Labcorp Buys Myriad Genetics’ Vectra Autoimmune Test Business

Labcorp has agreed to pay $150m in cash for Myriad Genetics’ autoimmune business, one of three major units Myriad is unloading as it tries to narrow its focus to oncology, women's health and mental health diagnostics.

Rheumatoid arthritis , Gouty arthritis ( Film x-ray hand of child with arthritis at multiple joint ) - Image ID: F83CXB
• Source: Alamy

Labcorp is improving expanding its rheumatoid arthritis diagnostics lineup by acquiring the Vectra rheumatoid arthritis assay from Myriad Genetics, which is getting out of the autoimmune diagnostics business to devote more resources to its oncology, mental health and women’s health businesses.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business